Hanseatic Management Services Inc Gilead Sciences, Inc. Transaction History

Hanseatic Management Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $390,570 - $444,980	5,052 New	5,052 $419,000
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $27,109 - $38,919	435 New	435 $37,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $44,442 - $51,840	-685 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $8,667 - $10,567	119 Added 21.02%	685 $52,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $3,913 - $4,593	55 Added 10.76%	566 $41,000
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $36,848 - $43,675	511	511 $41,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hanseatic Management Services Inc, based on Form 13F filings with the SEC.

Stay updated on Hanseatic Management Services Inc with notifications on news.